Managing Member Kevin McNish recently published an article on the Federal Circuit's decision in Sanofi-Aventis Deutschland GmbH v. Mylan Pharmaceuticals, Inc. in IAM, a leading intellectual property publication. The article provides tips for drafting patents and litigating analogous-art issues in view of that decision.

The article is available at the following link (external link, registration or subscription may be required): https://www.iam-media.com/article/us-sanofi-aventis-precedent-adds-toolbox-patentee-prosecution-and-litigation-success.

About McNish PLLC

McNish PLLC is a cloud-based law firm that provides full-stack solutions for Patent Trial and Appeal Board proceedings, including inter partes reviews (IPRs). From petition through appeal, for petitioners or for patent owners, McNish PLLC can do it all. And, by pairing the in-depth experience of Kevin McNish with innovative fee arrangements that avoid the pitfalls of hourly billing, McNish PLLC can deliver unparalleled value in PTAB proceedings and Federal Circuit appeals.

For more information, visit McNish PLLC’s website at www.mcnishpllc.com or email McNish PLLC at contact@mcnishpllc.com.